Similarly, inhibition of uPA by PAI-2 significantly increases the affinity of the complex for LRP, resulting in endocytosis of the uPA-PAI-2 complexes in prostate cancer cells (Croucher et al., 2006). Here, SERPINB2 is linked to prostate carcinoma.